Cancer Clinical Trial
Official title:
Targeted Health Dialogues in Primary Care: Lifestyle Screening and Molecular Profiling for a Healthier Life
The County Council of Region Skåne, Sweden, has recently initiated Targeted Health Dialogues in primary care. The prevention program includes health dialogues provided by specially trained personnel, collection of clinical and laboratory data as well as questionnaire data on, e.g., individual health and health behaviors. So far, it enrolls all 40-year old Swedish and foreign-born inhabitants in the county and it will also include all 50- and 60-year old persons within a near future. A research project will be integrated within the program where the collected data will be linked, on the individual level, to national and regional data on hospital admissions, clinical diagnoses from specialist clinics and primary care, causes of death, and prescriptions. The individual linkages will also include population data on sociodemographic characteristics, neighborhood of residence and family relations. Blood samples will be collected for analyses of molecular biomarkers. The research project will examine associations between potential predictors and future risk of cardiovascular diseases and other serious diseases, such as cancer, and also whether the effect of the prevention program is modified by these potential predictors. The effect of the intervention will be examined, and whether the protocol needs to be modified in order to develop more precise and personalized medicine.
Status | Recruiting |
Enrollment | 18000 |
Est. completion date | December 31, 2035 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | |
Gender | All |
Age group | 40 Years to 70 Years |
Eligibility | Inclusion Criteria: - 40-, 50-, 60-, and 70-year old men and women - Listed at a healthcare center in Skåne county Exclusion Criteria: * Inability to understand the written study information and give informed consent |
Country | Name | City | State |
---|---|---|---|
Sweden | Center for Primary Health Care Research, Lund University and Region Skåne | Malmö | Skåne |
Lead Sponsor | Collaborator |
---|---|
Region Skane |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effect of targeted health dialogues on CVD incidence | The short- and long-term effect of targeted health dialogues on incidence of CVD events, its comorbidity and CVD-related deaths in the participants compared to a general population cohort and historical controls. | 2035 | |
Primary | Effect of targeted health dialogues on incidence of cancer and other serious diseases | The short- and long-term effect of targeted health dialogues on incidence of cancer and other serious diseases in the participants compared to a general population cohort and historical controls. | 2035 | |
Secondary | Modification by individual characteristics | Modification of possible associations between targeted health dialogues and future CVD, cancer, other serious diseases and preterm death by individual characteristics (e.g., sociodemographic factors) | 2035 | |
Secondary | Association between risk factors and disease incidence | Associations between risk factors/combination of risk factors (lifestyle-related, metabolic, psychosocial and familial) at baseline and incidence of CVD, cancer, other serious diseases and preterm death. | 2035 | |
Secondary | Identification of molecular biomarkers | The ability of biological aging, epigenetic changes and genetic and metabolomic profiles to predict CVD, cancer, other serious diseases and preterm death as well as the effect of targeted health dialogues. | 2035 | |
Secondary | Public health profile of middle-aged citizens in Sweden's southernmost county | Level of physical activity and sedentary behavior, intake of healthy/unhealthy food, alcohol consumption, smoking habits, stress, psychological well-being, blood glucose, cholesterol, BMI, waist-hip ratio. Comparisons between subgroups: age, sex, sociodemography, previous diagnoses. | 2035 | |
Secondary | Associations between dental and general health | Associations between dental health at baseline and incidence of CVD, cancer, other serious diseases and preterm death. | 2035 | |
Secondary | Validation of the targeted health dialogue method | Validity and reliability of the questionnaire and targeted health dialogue method | 2035 | |
Secondary | Health economy | Costs related to the targeted health dialogues versus individual and societal gains. | 2035 | |
Secondary | The effect of targeted health dialogues on health behaviors and self-rated health | 2035 | ||
Secondary | Do targeted health dialogues reach all societal groups? | 2035 | ||
Secondary | Can other lifestyle interventions influence the effect of targeted health dialogues? | 2035 | ||
Secondary | Follow-up of samples taken after the targeted health dialogues. | Which samples and tests were taken as a result of the targeted health dialogues? | 2035 | |
Secondary | Do the the targeted health dialogues influence care seeking? | Evaluation of new search patterns due to the targeted health dialogues. | 2035 | |
Secondary | Obstacles and motivators for physical activity | What obstacles and motivators for physical activity do inactive people experience? | 2035 | |
Secondary | Effect of targeted health dialogues on blood metabolites | Do targeted health dialogues affect food-related metabolites in the blood? | 2035 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|